Literature DB >> 10229103

Activation and regulation of the IkappaB kinase in human B cells by CD40 signaling.

Y Kosaka1, D M Calderhead, E M Manning, J E Hambor, A Black, R Geleziunas, K B Marcu, R J Noelle.   

Abstract

This study demonstrates that the engagement of CD40 results in the activation of the recently described IkappaB kinase (IKK) in a human B cell line. The kinase appears to reside within the cell in a cytosolic signalsome complex consisting of IKK, IkappaB, and an MKP-1-like molecule. While the binding of CD154 to CD40 induces the assembly of a CD40-TRAF receptor complex, IKK is not recruited to this complex. Nonetheless, a functional link between TRAF2 and IKK activity in B cells is demonstrated by the fact that overexpression of TRAF2 constitutively induces IKK activity, NF-kappaB luciferase and Fas expression. Synergy in the activation of IKK and NF-kappaB-dependent gene expression was observed by the simultaneous engagement of the B cell receptor and CD40, establishing an early means for cross-talk between these two B cell activation pathways. This study discusses the sequential biochemical events that transpire upon CD40 engagement by its ligand in human B cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229103     DOI: 10.1002/(SICI)1521-4141(199904)29:04<1353::AID-IMMU1353>3.0.CO;2-2

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Naïve and memory B cells in the rhesus macaque can be differentiated by surface expression of CD27 and have differential responses to CD40 ligation.

Authors:  David Kuhrt; Seth Faith; Angela Hattemer; Amanda Leone; Donald Sodora; Louis Picker; Lisa Borghesi; Kelly Stefano Cole
Journal:  J Immunol Methods       Date:  2010-09-24       Impact factor: 2.303

2.  Tumour-necrosis-factor-receptor-associated factor 6, NF-kappaB-inducing kinase and IkappaB kinases mediate IgE isotype switching in response to CD40.

Authors:  K Brady; S Fitzgerald; P N Moynagh
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

3.  CD40 regulates the processing of NF-kappaB2 p100 to p52.

Authors:  H J Coope; P G P Atkinson; B Huhse; M Belich; J Janzen; M J Holman; G G B Klaus; L H Johnston; S C Ley
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

4.  Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism.

Authors:  Beatriz Gil-Araujo; María-Val Toledo Lobo; María Gutiérrez-Salmerón; Julia Gutiérrez-Pitalúa; Santiago Ropero; Javier C Angulo; Antonio Chiloeches; Marina Lasa
Journal:  Mol Oncol       Date:  2013-09-14       Impact factor: 6.603

5.  Characterizing Serpinb2 as a Modulator of TCDD-Induced Suppression of the B Cell.

Authors:  Peter Dornbos; Melanie Warren; Robert B Crawford; Norbert E Kaminski; David W Threadgill; John J LaPres
Journal:  Chem Res Toxicol       Date:  2018-10-30       Impact factor: 3.739

6.  Thyroid hormone antagonizes tumor necrosis factor-alpha signaling in pituitary cells through the induction of dual specificity phosphatase 1.

Authors:  Marina Lasa; Beatriz Gil-Araujo; Marta Palafox; Ana Aranda
Journal:  Mol Endocrinol       Date:  2009-12-23

7.  Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation.

Authors:  U D Bajpai; K Zhang; M Teutsch; R Sen; H H Wortis
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

Review 8.  Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host.

Authors:  Brandon Cieniewicz; Alexis L Santana; Nana Minkah; Laurie T Krug
Journal:  Front Microbiol       Date:  2016-08-17       Impact factor: 5.640

9.  The ligand-bound thyroid hormone receptor in macrophages ameliorates kidney injury via inhibition of nuclear factor-κB activities.

Authors:  Fumihiko Furuya; Toshihisa Ishii; Shogo Tamura; Kazuya Takahashi; Hidetoshi Kobayashi; Masashi Ichijo; Soichi Takizawa; Masahiro Kaneshige; Katsue Suzuki-Inoue; Kenichiro Kitamura
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.